---
title: "BUZZ-Johnson & Johnson falls after medical device sales miss quarterly estimates"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292757851.md"
datetime: "2026-07-15T11:23:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292757851.md)
  - [en](https://longbridge.com/en/news/292757851.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292757851.md)
---

# BUZZ-Johnson & Johnson falls after medical device sales miss quarterly estimates

Shares of healthcare conglomerate Johnson & Johnson (JNJ.N) down 1.9% at $248.91 premarket

Q2 sales at JNJ’s medical technology unit came in at $8.93 billion, below analysts’ average estimate of $8.97 billion - LSEG-compiled data

Co says unit’s sales hurt by a drop in demand for its Impella heart pumps, following a U.K. study that raised questions about the use of the pumps during high-risk coronary procedures

Reports Q2 adj. profit of $2.90 per share vs analysts’ average estimate of $2.85 per share

Q2 revenue of $25.31 billion beats analysts’ average expectation of $25.05 billion

JNJ attributes revenue to strong growth from immunology drug Tremfya and cancer blockbuster Darzalex

Up to last close, stock up 22.7% YTD

### Related Stocks

- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [LSEG.UK](https://longbridge.com/en/quote/LSEG.UK.md)

## Related News & Research

- [J&J, Time to name Healthcare Champion of the Year](https://longbridge.com/en/news/293242387.md)
- [BUZZ-Street View: Device blues can't dim J&J's pipeline glow](https://longbridge.com/en/news/292869702.md)
- [Dorsey Wright & Associates Buys 8,953 Shares of Johnson & Johnson $JNJ](https://longbridge.com/en/news/293179677.md)
- [Johnson & Johnson wins FDA De Novo clearance for OTTAVA robotic surgery system in US](https://longbridge.com/en/news/293462534.md)
- [J&J names C1DO1, Curium Life Tech, iQ Surgical as Polyphonic AI Fund for Surgery cohort at SRS meeting](https://longbridge.com/en/news/293630635.md)